ACC GUIDELINES Bundle (free trial)

Atrial Fibrillation

ACC GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/387793

Contents of this Issue

Navigation

Page 53 of 131

54 Management Table 14. Situations in Which Long-Term Anticoagulation Is Contraindicated and Situations When It Remains Reasonable Long-Term Anticoagulation Contraindicated Long-Term Anticoagulation is Still Reasonable • Severe bleeding due to a nonreversible cause involving the gastrointestinal, pulmonary, or genitourinary systems • Spontaneous intracranial/intraspinal bleeding due to a nonreversible cause • Serious bleeding related to recurrent falls when cause of falls is not felt to be treatable • Bleeding involving the gastrointestinal, pulmonary, or genitourinary systems that is treatable • Bleeding related to isolated trauma • Bleeding related to procedural complications 6.5.1. Percutaneous Approaches to Occlude the Left Atrial Appendage (LAA) COR LOE Recommendations 2a B-NR 1. In patients with AF, a moderate to high risk of stroke (CHAD 2 DS 2 -VASc score ≥2), and a contraindication (Table 14) to long-term oral anticoagulation due to a nonreversible cause, percutaneous LAAO (pLAAO) is reasonable. 2b B-R 2. In patients with AF and a moderate to high risk of stroke and a high risk of major bleeding on oral anticoagulation, pLAAO may be a reasonable alternative to oral anticoagulation based on patient preference, with careful consideration of procedural risk and with the understanding that the evidence for oral anticoagulation is more extensive.

Articles in this issue

Archives of this issue

view archives of ACC GUIDELINES Bundle (free trial) - Atrial Fibrillation